Regeneron Pharmaceuticals, Inc. (REGN)
721.05
+18.78
(+2.67%)
USD |
NASDAQ |
May 06, 16:00
721.05
0.00 (0.00%)
After-Hours: 06:14
Regeneron Pharmaceuticals SG&A Expense (TTM) : 2.715B for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amgen, Inc. | 6.965B |
| Eli Lilly & Co. | 11.56B |
| Merck & Co., Inc. | 10.88B |
| Pfizer Inc. | 10.76B |
| AbbVie, Inc. | 14.30B |